Heart surgery sedative may shield your memory
NCT ID NCT06655025
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether giving the sedative dexmedetomidine during open heart surgery can help protect patients' thinking and memory afterward. Researchers measured brain function with a simple test and checked a blood marker of brain injury. The trial included 32 adults having elective open heart surgery, and results may show whether this drug reduces cognitive decline.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Dexmedetomidine (a sedative drug given during surgery)
- What this could lead to
- If it works, this could point toward a simple way to protect thinking and memory after open heart surgery.
- What could go wrong
- This is a very small, completed trial with only 32 patients. Results may not apply to everyone, and the drug can cause slow heart rate or low blood pressure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC SURGERY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sohag University
Sohag, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could continuing a common heart drug before surgery save lives?
- Could waking up in the operating room speed heart surgery recovery?
- Can a simple frailty check predict how well seniors recover from heart surgery?
- Could a simple scheduling change ease heart surgery nerves?
- Calcium timing during bypass may cut need for heart drugs
- Heart surgery recovery gets a wireless watchdog